Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: An investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years

Journal of Clinical Pathology - Molecular Pathology

Volumn 50, Issue 4, 1997, Pages 212-217

  Lundemose, J B ^a   Kolvraa S ^b   Gregersen, N ^c   Christensen, E ^d   Gregersen, M ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b Institute of Human Genetics

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Children; Diagnosis; Fatty acid oxidation disorders

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; MYRISTIC ACID;

ARTICLE; FATTY ACID OXIDATION; FIBROBLAST CULTURE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SUDDEN DEATH; SUDDEN INFANT DEATH SYNDROME; URINALYSIS;

EID: 0030693188     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.50.4.212     Document Type: Article

References (38)

1. Gregersen N, Andresen BS, Bross P, Bolund L, Kølvraa S. Disorders of mitochondrial fatty acid oxidation especially medium-chain acyl Co A dehydrogenase (MCAD) deficiency. In: Farriaux JP, Dhondt JL, eds. New horizons in nconatal screening. Amsterdam: Elsevier, 1995:247-55.
2. Roe CR, Croates PM. Mitochondrial fatty acid disorders. In: Scriver CR, Beudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 1995:1501-33.
3. Aoyama T, Souri M, Ushikubo S, Kamijo T, Yamaguchi S, Kelley RI, et al Purification of human very-long-chain acyl-coenzyme A dehydrogenase A and characterization of its deficiency in seven patients. J Clin Invest 1995;95:2465-73.
4. Harpey JP, Charpentier C, Paturneau-Jouas M. Sudden infant death and inherited disorders of fatty acid beta-oxidation. Biol Neonate 1990;58(Suppl):70-80.
5. Politt RJ. Defects in mitochondrial fatty oxidation: clinical presentations and their role in sudden infant death. Paediatr Paedol 1993;28:13-7.
6. Andresen BS, Bross P, Winter V, Kølvraa S, Jensen T, Bolund L, et al. A rare disease-causing mutation in the medium-chain acyl CoA dehydrogenase (MCAD) gene changes a conserved arginine, previously shown to be functionally essential in short-chain acyl-CoA dehydrogenase (SCAD). Am J Hum Genet 1993;53:730-9.
7. Brackett JC, Sims HF, Steiner RD, Nunge M, Zimmermann EM, deMartinville B, et al. A novel mutation in medium-chain acyl-CoA dehydrogenase causes sudden neonatal death. J Clin Invest 1994;94:1477-83.
8. Tanaka K, Yokota I, Coates PM, Strauss AW, Kelly DP, Zhang Z, et al. Mutation in the medium-chain acyl-CoA dehydrogenase (MCAD) gene. Hum Mutation 1992;1:271.
9. Mutations causing medium-chain acyl-CoA dehydrogenase deficiency: a collaborative compilation of data from 172 patients. In: Coates PM, Tanaka K, eds. New development in fatty oxidation. New York: Wiley-Liss, 1992;499-506.
10. Iafolla AK, Thompson RJ, Roe CR. Medium-chain acyl-CoA dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994;124:409-15.
11. Blakemore AIF, Singleton H, Politt R, Engel PC, Kølvraa S, Gregersen N, et al. The frequency of the G985 MCAD mutation in the general population. Lancet 1991;337:2989.
12. Gregersen N, Winter V, Curtis D, Deufel T, Willems P, Ponzone A, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: the prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe. HUM Hered 1993;43:342-50.
13. Matsubara Y, Narisawa K, Tada K, Ikeda H, Ye-qi Y, Danks DM, et al. Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards. Lancet 1991;358:552-3.
14. Gregersen N, Winter V, Kølvraa S, Andresen BS, Bross P, Blakemore AIF, et al. Molecular analysis of medium-chain acyl-CoA dehydrogenase deficiency: a diagnostic approach. In: Coates PM, Tanaka K, eds. New development in fatty oxidation. New York: Wiley-Liss, 1992:441-52.
15. Gregersen N, Lauritzen R, Rasmussen K. Suberylglycine excretion in the urine of a patient with dicarboxylic aciduria. Clin Chim Acta 1976;70:417-25.
16. Duran M, Hofkamp M, Rhead WJ, Saudubray JM, Wadman SK. Sudden child death and "healthy" affected family members with medium-chain acyl-CoA dehydrogenase deficiency. Pediatrics 1986;78:1052-7.
17. Nobukuni V, Yokoo T, Ohtani Y, Endo F, Aoki S, Yoshinaga M, et al. Neonatal onset of medium-chain acyl-CoA dehydrogenase deficiency in two siblings. Brain Dev 1988;10:129-34.
18. Catzeflis C, Bachmann C, Hale DM, Coates PM, Wiesmann U, Colombo JP, et al. Early diagnosis and treatment of neonatal medium-chain acyl-CoA dehydrogenase deficiency: report of two siblings. Eur J Pediatr 1990;146:577-81.
19. Bennett MJ, Allison F, Politt RJ, Variend S. Fatty acid oxidation detects as cause of unexpected death in infancy. In: Tanaka K, Coates, PM, eds. Fatty oxidation clinical. biochemical and molecular aspects. New York: Alan R Liss, 1990:349-64.
20. Gregersen N, Blakemore AIF, Winter V, Andresen BS, Kølvraa S, Bolund L, et al. Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point-mutation (G985) in the MCAD gene. Clin Chim Acta 1991;203:23-1.
21. Lundemose JB, Gregersen N, Kølvraa S, Petersen BN, Gregersen M, Helweg-Larsen K, et al. The frequenzy of a disease-causing point-mutation in the gene coding for medium-chain acyl-CoA dehydrogenase (MCAD) in sudden infant death syndrome (SIDS). Acta Paediatr 1993;- 82:544-6.
22. Holten JB, Allen JT, Green CA, Partington S, Gilbert RE, Berry PJ. Inherited metabolic diseases in sudden infant death syndrome. Arch Dis Child 1991;66:1315-7.
23. Miller ME, Brooks JG, Forbes N, Insel R. Frequency of medium-chain acyl-CnA dehydrogenase deficiency G-985 mutation in sudden infant death syndrome. Pediatr Res 1992;31:305-7.
24. Chinsky J, Tolsma T, Cowan T, Blitzer M. MCAD deficiency in SIDS. Am J Hum Gen 1991;49(Suppl):A183.
25. Arens R, Gozal D, Jain K, Muscati S, Heuser ET. Williams JC, et al. Prevalence of medium-chain acyl-CoA dehydrogenase deficiency in sudden infant death syndrome. J Pediatr 1093;122:715-8.
26. Bergman AB, Berkwith JB, Ray CC. Sudden infant death syndrome. Seattle: University of Washington Press, 1970:17-8.
27. Gregersen M, Rajs J, Laursen H, Baandrup U, Frederiksen P, Gidlund E, et al. Pathologic criteria for the Nordic study of SIDS. In: Rognum TO, ed. Sudden infant death syndrome, new trends in the minetics. Oslo: University Press, 1995:50-8.
28. Manning NJ, Olpin SE, Politt RJ, Webley J. A comparison of [9,10-3] myristic acids for the detection of defects of fatty acid oxidation in infact cultured fibroblasts. J Inher Metab Dis 1990;13:58-68.
29. Gregerson N, Winter V, Lyonnet S, Saududray JM, Wendel U, Jensen TG, et al. Molecular characterization and urinary excretion pattern of metabolites in two families with MCAD deficiency due to compound heterozygocity with a 13 base-pair insertion on one allele. J Inher Metab Dis 1994;17:169-84.
30. Kwok S, Kelogg DE, McKinney N, Spasic D, Goda L, Levenson C, et al. Effect of primer-template mismatches on polymerase chain reaction. Human immunodeficiency virus type 1 model studies. Nucleic Acids Res 1990;18:999-1005.
31. Gregersen N, Winter V, Jensen PKA, Kølvraa S, Andresen BS, Bross P, et al. Prenatal diagnosis of medium-chain acyl CoA dehydrogenase (MCAD) deficiency in a family with a fatal case of sudden unexpected death in childhood. Prenatal Diagn 1995;15:82-6.
32. Boles RG, Martin SK, Bhtzer MG, Rinaldo P. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver. Hum Pathol 1994;25:735-41.
33. Bennett MJ, Powel S. Metabolic disease and sudden, unexpected death in infancy. Hum Pathol 1991;25:742-6.
34. Miller M, Brooks J, Forbes N, Insel R. Frequency of G-985 mutation in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in sudden infant death syndrome. Prog Clin Biol Res 1992;375:495-8.
35. Lemieux B, Giguerre R, Cyr D, Shapcott D, McCann M, Tuchman M. Screening urine of 3-week-old newbrons: lack of association between sudden infant death syndrome and some metabolic disorders. Pediatrics 1993;85:986-8.
36. Gregersen N, Kølvraa S, Rasmussen K, Mortensen PB, Divry P, David M, et al. General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biological significant organic acids in 3 cases Clin Chim Acta 1983;132:181-91.
37. Frerman FE, Goodman SI. Nuclear encoded defect of mitochondrial respiratory chain, including glataric acidemia type II. In: Scriver CR, Beudet AI., Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. New York: McGraw Hill, 1995:1611-30.
38. Bonell HJ, Beckwith JB. Fatty liver in sudden childhood death: implications for Reye's syndrome? Am J Dis Child 1986;140:30-3.